By Julie Steenhuysen CHICAGO (Reuters) -Thousands of Americans campaigning for the Novavax COVID-19 booster got some good ...

The company says its vaccine is on track for full approval, following delay. Novavax shares soared following the announcement ...

Novavax said on Wednesday U.S. regulators asked the company to produce more data on its COVID-19 vaccine if it gets full ...

Novavax said on Wednesday the U.S. Food and Drug Administration had asked the company to produce more data on its COVID-19 ...

Novavax's COVID-19 vaccine showed fewer side effects than Pfizer's in a Utah study as FDA seeks more data before full ...

serving as the basis of Pfizer’s RSV vaccine. Variations in the F protein sequence among RSV-A and RSV-B subgroups are clustered in a key antigenic site, a target for potent neutralizing antibodies.

Just days after its advisory committee meeting voted to approve a third dose of Pfizer and BioNTech's COVID-19 vaccine, the FDA has followed through and cleared the shot.

Pfizer is a pharmaceutical and biotechnology company that developed a COVID-19 vaccine that was approved by the FDA in August 2021. The three top individual/insider shareholders in Pfizer are ...

The FDA has approved new versions of Pfizer/BioNTech's Comirnaty and Moderna's Spikevax COVID-19 vaccines that target the Omicron KP.2 strain of SARS-CoV-2 which was dominant in the US in recent ...

On Wednesday, the Advisory Committee on Immunization Practices (ACIP) voted to expand its recommendation for the use of respiratory syncytial virus (RSV) vaccines approved for adults 50-59 years ...

Trump stands behind Hegseth after attack plans shared in second Signal chat President Donald Trump said on Monday that he stood behind U.S. Defense Secretary Pete Hegseth, after reports that he ...